ABEO (abeonatherapeutics.com) Forvard P/S multiplikatori

Abeona Therapeutics Inc. (ABEO) korporativ emblemasi va logotipi

Abeona Therapeutics (ABEO) epidermoliz bulloza bilan kurashish uchun noyob gen terapiyasini ishga tushirishga tayyorgarlik ko'rmoqda. Biroq, global beqarorlik va sanksiyalar biomateriallarni tashishni murakkablashtirmoqda, bu esa kengayishni cheklaydi. Ichki imkoniyatlar va oftalmologiya sohasidagi tadqiqotlar o'zgaruvchanligi ishlanish risklarini yumshatadi. Kompaniyaning kelajakdagi P/S koeffitsiyenti tendentsiyasi bozor kutganlarini aniq ko'rsatadi, bunda joriy qiymat 3.50 ga tengdir.

Abeona Therapeutics, Inc. - ABEO Forvard P/S multiplikatori (davr: 04.07.2022 - 15.11.2026)

Abeona Therapeutics Inc. (ABEO) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning fundamental tahlili:Abeona Therapeutics ABEO
abeonatherapeutics.com original mahsuloti

Diversifikatsiyalashgan biokomponent yetkazib berish zanjirlari Abeona Therapeutics (ABEO) uchun operatsion xatarlarni minimallashtirib, daromadning bashorat qilinadigan o'sishi uchun asos yaratadi. Forward P/S metrikasini tahlil qilishda investor biznesning bozor qiymati va kutilayotgan savdo hajmi nisbatini baholaydi; grafikda ushbu nisbatning pasayishi aktivning qadri past baholanganini anglatishi mumkin, oshishi esa kelajakdagi pul oqimlari bo'yicha bozor kutuvlarining ortiqchaligidan dalolat beradi.

Abeona Therapeutics raqobatchilari

Narxning prognoz qilingan daromadga nisbati Vertex VRTX|ALNY (Alnylam Inc.) - Kelajakdagi narxning daromadga nisbati|Insmed Incorporated - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx UTHR (United Therapeutics)|BMRN: Forvard P/S multiplikatori|BridgeBio Pharma (BBIO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati bgm.ltd|COGT: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati xerispharma.com (XERS)|Forvard narx/daromad multiplikatori Keros Therapeutics KROS|Forvard P/S multiplikatori ARCT (arcturusrx.com)|Forvard P/S multiplikatori Eton Pharmaceuticals, Inc. ETON|KMDA - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati FULC|MREO: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Protalix BioTherapeutics, Inc. (PLX)|PLRX (Pliant Therapeutics, Inc.) - Forvard P/S multiplikatori|Applied Therapeutics Inc. - Kelajakdagi narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Rein Therapeutics Inc (RNTX)|Narxning kutilayotgan daromadga nisbati GELS|Aytu BioPharma, Inc. - Forvard narx/daromad multiplikatori|Chemomab Therapeutics (CMMB) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|SRx Health - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Polyrizon Limited PLRZ|AEZS: Forvard P/S multiplikatori|CYTH: Narxning kutilayotgan daromadga nisbati|Forvard narx/daromad multiplikatori INZY|RPHM: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori CSCI (COSCIENS Biopharma)